A new mouse model mimicking the liver symptoms of myotonic dystrophy type 1—the most prevalent form of adult-onset muscular dystrophy—provides insight into why patients develop fatty liver disease and display hypersensitivity ...
Oct 24, 2024
0
41
Scientists at the Agency for Science, Technology and Research (A*STAR) and the Shanghai Institute of Immunology (SII), along with their international collaborators, have dissected the key signaling mechanism driving inflammation ...
Oct 15, 2024
0
35
New research from the University of Missouri School of Medicine suggests intensive lifestyle interventions are an effective way of treating and improving liver disease.
Oct 9, 2024
0
0
Metabolic dysfunction-associated steatotic liver disease (MASLD)—previously known as "non-alcoholic fatty liver disease"—affects about 25% of the global population. Its severe form, metabolic dysfunction-associated steatohepatitis ...
Oct 9, 2024
0
0
Our imagination for artificial intelligence is expansive and ambitious. While there are plenty of dystopian tropes, pop culture is full of hopeful examples of what we believe artificial intelligence could bring to us, ranging ...
Oct 3, 2024
0
0
Monash University researchers have discovered how the hormone peptide glucagon could better treat conditions such as obesity and type 2 diabetes, which affect billions of people.
Oct 2, 2024
0
2
Medical science has long been on the hunt for a deeper understanding of the devastating scarring of the body's organs known as fibrosis, which leads to irrevocable loss of function.
A new type of blood test using lipids could make it easier to identify children at risk of complications around obesity including type two diabetes, liver and heart disease, say scientists.
Sep 20, 2024
0
31
In the fight against fatty liver disease, researchers are looking for any and all possible solutions. But to combat the disease, which is also known as metabolic dysfunction-associated steatotic liver disease, or MASLD, scientists ...
Sep 18, 2024
0
33
Fatty liver disease linked to diabetes and obesity can easily progress to liver cirrhosis, but new research suggests that GLP-1 medicines like Ozempic can help stop that.
Sep 16, 2024
0
12
